Maternal age and gestational age-specific risk for chromosomal defects.
about
Second trimester serum tests for Down's Syndrome screeningUrine tests for Down's syndrome screeningFirst trimester serum tests for Down's syndrome screeningThe maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458].Combined first-trimester screening in northern Finland: experiences of the first ten years.Increased fetal nuchal translucency at 11-14 weeks.Coincidence of trisomy 18 and robertsonian (13; 14).The impact of Down syndrome screening on Taiwanese Down syndrome births: a nationwide retrospective study and a screening result from a single medical centre.Sonographic markers for early diagnosis of fetal malformations.The cost effectiveness of prenatal ultrasound screening for trisomy 21.First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.Increased risk of congenital heart disease in twins in the North of England between 1998 and 2010.A case of triploidy detected by crosstrimester test.Prenatal Risk Calculation (PRC) 3.0: An Extended DoE-Based First-Trimester Screening Algorithm Allowing For Early Blood Sampling.NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results.A comparative cytogenetic study of miscarriages after IVF and natural conception in women aged under and over 35 years.Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.Sex ratio of congenital abnormalities in the function of maternal age: a population-based study.Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.Intrauterine death in singleton pregnancies with trisomy 21, 18, 13 and monosomy X.Prenatal sonographic features of triploidy at 12-16 weeks.Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.Risk assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness in 7,096 unselected pregnancies in Slovenia.Antenatal detection of Edwards (Trisomy 18) and Patau (Trisomy 13) syndrome: England and Wales 2005-2012.Biparietal diameter at 11 to 13 weeks' gestation in fetuses with holoprosencephaly.Distribution of maternal age and birth order groups in cases with unclassified multiple congenital abnormalities according to the number of component abnormalities: a national population-based case-control study.Detection of triploidy at 11-14 weeks' gestation: a cohort study of 198 000 pregnant women.Revisiting the risk for aneuploidy in fetuses with isolated pyelectasis.Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening.Extrapolation of maternal weight in sequential aneuploidy screening.First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation.Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test.Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13.Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.Screening and outcome of chromosomal abnormalities other than trisomy 21 in Northern Finland.Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.First-trimester screening for trisomy 21 with adjustment for biochemical results of previous pregnancies.
P2860
Q22252964-6D4419C8-2896-4499-B980-B332C1CA0C2BQ24186912-25C11EF2-7C5C-40CF-A864-2D5602906CD7Q24187589-F9E44A21-C46A-454D-9D0F-A9C946EA81E1Q31089104-C6616AF6-87C9-4F76-97C5-28CC428A9221Q33239775-0E51F26D-0602-4B9E-9298-27A0882E2B5CQ34035276-5197C88C-46AE-42BB-8322-3F6194FD26A5Q34618589-6BA97FDA-B793-4305-A46F-A618AE45A852Q34644784-24D2B805-7D69-44E9-927A-064A10E0A741Q35023654-5C048A2E-71F9-4CBB-BA8F-A26915246E8DQ35030149-77E39907-B0F7-400D-9CF5-C219D462BAA2Q35989243-7DCCD11A-CF07-4DF9-B5D9-F59DA0A7EEDAQ36308489-35A7F8F2-A47B-45AC-AC14-7AB19F0CE367Q36308492-B293576A-F7C6-44C6-B914-571B16E18147Q36374779-DB84D27C-A631-47B3-B6E9-64236B57B42EQ36415842-633B224C-6DA9-4024-9B90-B9CB9BA0B704Q37255885-972A5E45-B3DD-4D0B-9C5A-745DA1E8709DQ37472073-C132ADF2-7391-4DFC-B4C4-EF12389E6F2AQ37601074-615DFF20-C400-4EB8-837D-679A13FAC671Q38976722-3B383E83-6DAE-44D5-B07D-153CBD1E7EC8Q40231577-11F73FD9-CF18-4D61-A6E5-A58123B8B384Q40524568-0B7D6ED9-174A-4046-A7EA-C9346F309375Q40759826-2B6EBDE0-75CE-4FE8-BF09-9DF4BFB41B30Q40773197-B60B8D3D-D76D-4E3B-B40B-B3DF13F301C1Q43418239-8B5C14AC-1ABC-43DF-8602-DEAC68209F65Q43513411-CA00E512-2C79-48AC-AC37-DC7C5923DAD7Q44636320-DFF1700B-5A9D-4737-96AB-24F17E92F06BQ44765854-626FC9B1-E4CB-42DA-A28F-0EC9286AA381Q44771185-69FF51CF-E595-46E5-B5B6-652DF8475678Q45018111-BE9C5A8C-97C8-4941-9CD0-553D4120D01EQ45823428-624C5C2D-CF05-460E-96F7-6E5DA8BBA87CQ46925141-7C0069D1-CD02-4D3D-98DE-688983797810Q47178004-34717A6F-91B8-4B71-9B77-251AF81000A6Q47580912-BF27E8B4-6601-4351-BCB8-2B2C8FA75EA3Q47584326-AFE11598-A183-4021-92F3-6E187477E03EQ47641657-94E63E56-AF7F-4F6D-8621-C2A312A849A0Q47806926-61358F0C-672A-4C27-B89D-E2067E7F4823Q50920332-0F5C70A0-EEDA-4868-8452-5EB38DB17963Q51035991-01C3842F-D6C2-43CA-AD99-29D6CC63AE2FQ51321305-BF8F5594-A4C1-4CC0-9208-E09AC1A136BAQ51553678-FBC11394-D2CC-41F5-96AA-5490C9C7DD89
P2860
Maternal age and gestational age-specific risk for chromosomal defects.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Maternal age and gestational age-specific risk for chromosomal defects.
@ast
Maternal age and gestational age-specific risk for chromosomal defects.
@en
Maternal age and gestational age-specific risk for chromosomal defects.
@nl
type
label
Maternal age and gestational age-specific risk for chromosomal defects.
@ast
Maternal age and gestational age-specific risk for chromosomal defects.
@en
Maternal age and gestational age-specific risk for chromosomal defects.
@nl
prefLabel
Maternal age and gestational age-specific risk for chromosomal defects.
@ast
Maternal age and gestational age-specific risk for chromosomal defects.
@en
Maternal age and gestational age-specific risk for chromosomal defects.
@nl
P2093
P356
P1476
Maternal age and gestational age-specific risk for chromosomal defects.
@en
P2093
Nicolaides KH
Snijders RJ
P304
P356
10.1159/000264259
P577
1995-11-01T00:00:00Z